Soleno Therapeutics (SLNO) is up 10.6%, or $6.05 to $62.90.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLNO:
- Video: Lithium Americas jumps amid talks with DOE, General Motors on loan
- Morning Movers: uniQure skyrockets after AMT-130 trial meets primary endpoint
- Soleno jumps 11% to $63.37 after Acadia trial miss
- Wells sees Soleno’s shares trading up at least 20% on Acadia’s failure in PWS
- Positive Market Outlook for Soleno Therapeutics’ Vykat XR in Prader-Willi Syndrome Treatment